Login | Register

Xarelto (Rivaroxaban) J&J Anti Clot Trials Looking Good

Johnson & Johnson's blood clot preventer Xarelto has come out well in clinical trials, with results comparable to other treatments for blood clotting in the lungs. A study of nearly 5000 patients showed effectiveness and safety were on par with anything else on the market, meaning the drug is poised to move forwards and possibly become a front-runner for hospitals around the world...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *